-
A clinical trial in Australia of muvalaplin found it can lower lipoprotein-A or Lp(a) by more than 50%. A North Texas cardiologist says it could be a game-changer.
-
Senate Bill 989 requires health insurers to cover biomarker testing. Dr. Chris Prokash of Texas Oncology says this opens access to more targeted and effective therapies.
-
There's no cure for congestive heart failure, but a North Texas cardiologist talks with KERA's Sam Baker about how more walking can improve a patient's quality of life.
-
A North Texas epidemiologist talks about why EG.5 has spread so quickly, and whether new booster shots expected this fall will be effective against the variant.
-
The director of UT Southwestern's Hospital Elder Life Program explains why time in the hospital can lead to cognitive problems for some older adults.
-
Dallas, Denton and Tarrant counties have reported at least six human cases of the mosquito-borne disease that can affect the central nervous system or the brain.
-
A North Texas expert on environmental toxicology and industrial chemical exposure explains why the average individual has little to fear.
-
Trials show the recently FDA-approved drug works for early-stage Alzheimer's patients. But a Fort Worth doctor says there are side effects to consider.
-
Data from U.S. studies over 40 years found some heart attack victims experienced cognitive decline at a more accelerated rate as they aged than patients without underlying heart disease.
-
KERA’s Sam Baker talks about the vaccines with Dr. Donna Casey, an internal medicine physician with Texas Health Presbyterian Hospital Dallas.
-
As North Texas hits triple digit temperatures this week, the chief of Emergency Medical Services at Parkland Hospital System explains the symptoms to watch for and how best to avoid heat-related illnesses.
-
A North Texas oncologist shares early signs to watch for, and how immunotherapy can help battle advanced cases.